⚡ Article Synopsis: In this article, OracleBio's Chief Scientific Officer, Lorcan Sherry, discusses the intricacies of AI-driven nuclear segmentation and the crucial factors that influence its accuracy in detecting and segmenting nuclei in tissues and cells.Over the...
.
R&D
Behind the Scenes: The Role of R&D in OracleBio
In July 2021, the creation of OracleBio’s dedicated Research & Development group marked an important milestone in our growth strategy. In this article, we go behind the scenes and take a retrospective look at what we have achieved over the past year, and give you...
OracleBio and the INCISE collaboration project
Bowel cancer is currently the second most deadly cancer in the UK, accounting for 10% of all cancer deaths. The current screening protocol for this type of malignancy involves a colonoscopy for patients who test positive for blood in their stool. About one in three of...